`571.272.7822
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Paper 17
`
` Date: March 24, 2021
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG, NOVARTIS TECHNOLOGY LLC, and
`NOVARTIS PHARMACEUTICALS CORP.,
`Patent Owner.
`____________
`
`IPR2020-01317
`Patent 9,220,631 B2
`____________
`
`
`
`
`
`Before Eric W. Hawthorne, Supervisory Trial Paralegal
`
`
`
`
`
`NOTIFICATION OF RECEIPT OF POP REQUEST
`
`The Office has received a request for Precedential Opinion Panel (POP)
`review of an issue raised in this case. See Ex. 3003. The request is under review.
`The Office will provide another notification after a decision on the request has
`been made.
`
`
`
`
`IPR2020-01317
`Patent 9,220,631 B2
`
`
`For PETITIONER:
`
`Elizabeth Weiswasser
`Anish Desai
`Brian Ferguson
`Christopher Pepe
`elizabeth.weiswasser@weil.com
`anish.desai@weil.com
`brian.ferguson@weil.com
`christopher.pepe@weil.com
`
`FOR PATENT OWNER:
`
`Elizabeth Holland
`William James
`Linnea Cipriano
`Joshua Weinger
`eholland@goodwinprocter.com
`wjames@goodwinlaw.com
`lcipriano@goodwinlaw.com
`jweinger@goodwinprocter.co
`
`
`
`2
`
`